RT Journal Article
SR Electronic
T1 The effectiveness of interventions to reduce COVID-19 transmission in a large urban jail
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.16.20133280
DO 10.1101/2020.06.16.20133280
A1 Malloy, Giovanni S. P.
A1 Puglisi, Lisa
A1 Brandeau, Margaret L.
A1 Harvey, Tyler D.
A1 Wang, Emily A.
YR 2020
UL http://medrxiv.org/content/early/2020/06/18/2020.06.16.20133280.abstract
AB Objectives To estimate the impact of various mitigation strategies on COVID-19 transmission in a U.S. jail beyond those offered in national guidelines.Methods We developed a stochastic dynamic transmission model of COVID-19 in one large urban U.S. jail among staff and incarcerated individuals. We divided the outbreak into four intervention phases: the start of the outbreak, depopulation of the jail, increased proportion of people in single cells, and asymptomatic testing. We used the next generation method to estimate the basic reproduction ratio, R0, in each phase. We estimated the fraction of new cases, hospitalizations, and deaths averted by these interventions along with the standard measures of sanitization, masking, and social distancing interventions.Results For the first outbreak phase, the estimated R0 was 8.23 (95% CrI: 5.01-12.90), and for the subsequent phases, R0,phase 2 = 3.58 (95% CrI: 2.46-5.08), R0,phase 3 = 1.72 (95% CrI: 1.41-2.12), and R0,phase 4 = 0.45 (95% CrI: 0.32-0.59). In total, the jail’s interventions prevented approximately 83% of projected cases and hospitalizations and 89% of deaths over 83 days.Conclusions Depopulation, single celling, and asymptomatic testing within jails can be effective strategies to mitigate COVID-19 transmission in addition to standard public health measures.Policy Implications Decision-makers should prioritize reductions in the jail population, single celling, and testing asymptomatic populations, as additional measures to manage COVID-19 within correctional settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge the anonymous jail for their prompt collaboration and transparency in providing detailed data on COVID-19 transmission. At the time that this work was conducted, G.M. was supported by grant number T32HS026128 from the Agency for Healthcare Research and Quality and L.P. was partially supported by the Veterans Health Administration. The content is solely the responsibility of the authors and does not necessarily represent the policy or views of the Agency of Healthcare Research and Quality, the Veterans Health Administration or the United States Government. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was deemed exempt from IRB review by the Yale Human Investigation Committee as we received completely anonymized data from the jail.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data was made available through the cooperation of an anonymous large urban jail under a data sharing agreement. Please contact GM for questions regarding sharing availability.